Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1992-12-18
pubmed:abstractText
We have investigated the direct effect of dimethyl prostaglandin A1 (dmPGA1) on the replication of herpes simplex virus (HSV) and human immunodeficiency virus type 1 (HIV-1). dmPGA1 significantly inhibited viral replication in both HSV and HIV infection systems at concentrations of dmPGA1 that did not adversely alter cellular DNA synthesis. The 50% inhibitory concentration (ID50) for several HSV type 1 (HSV-1) strains ranged from 3.8 to 5.6 micrograms/ml for Vero cells and from 4.6 to 7.3 micrograms/ml for human foreskin fibroblasts. The ID50s for two HSV-2 strains varied from 3.8 to 4.5 micrograms/ml for Vero cells; the ID50 was 5.7 micrograms/ml for human foreskin fibroblasts. We found that closely related prostaglandins did not have the same effect on the replication of HSV; dmPGE2 and dmPGA2 caused up to a 60% increase in HSV replication compared with that in untreated virus-infected cells. HIV-1 replication in acutely infected T cells (VB line) and chronically infected macrophages was assessed by quantitative decreases in p24 concentration. The effective ID50s were 2.5 micrograms/ml for VB cells acutely infected with HIV-1 and 5.2 micrograms/m for chronically infected macrophages. dmPGA1 has an unusual broad-spectrum antiviral activity against both HSV and HIV-1 in vitro and offers a new class of potential therapeutic agents for in vivo use.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-212521, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-2426284, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-2536171, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-2704750, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-2813398, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-3010301, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-3030346, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-3036736, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-3040001, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-3162731, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-3198648, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-3456266, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-3924371, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-6157190, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-6185627, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-6198441, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-6244226, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-6289665, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-6294110, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-6572555, http://linkedlifedata.com/resource/pubmed/commentcorrection/1332592-6606682
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2253-8
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Effects of dimethyl prostaglandin A1 on herpes simplex virus and human immunodeficiency virus replication.
pubmed:affiliation
Research Service, Veterans Administration Medical Center, San Francisco, California 94121.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S.